ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1133

The Relation of Serum Urate to Radiographic Knee Osteoarthritis in 2 Cohorts: The ELSA-Brasil MSK and the Original Cohort of the Framingham Heart Study

Ana Beatriz Vargas-Santos1, Tuhina Neogi2, Luciana Machado3, Isabela Beseñor4, Luciana Costa-Silva5, David Felson6, Sandhi Barreto7 and Rosa Telles8, 1Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2Boston University School of Medicine, Boston, MA, 3Clinical Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 4Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 5Instituto Hermes Pardini. Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 6Boston University, Boston, MA, 7Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 8Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

Meeting: ACR Convergence 2021

Keywords: Osteoarthritis, Uric Acid, Urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Osteoarthritis – Clinical Poster III (1118–1134)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Hyperuricemia may contribute to the development and/or progression of knee osteoarthritis (OA), based on increased inflammation associated with elevated serum urate (SU). Because hyperuricemia and OA are both associated with obesity, the direction and magnitude of the relation between them need to be thoroughly evaluated, taking the body mass index (BMI) into account. The identification of SU as a modifiable factor in the pathogenesis of OA could lead to the trial use of urate-lowering drugs as potential adjuvant therapy for OA. Therefore, we evaluated the relation of SU to radiographic knee OA (ROA) in two large cohorts unselected for OA, accounting for BMI.

Methods: This was a cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health – Musculoskeletal Study (ELSA-Brasil MSK) cohort, mirroring a previous analysis performed on the original cohort of the Framingham Heart Study (FHS), comparing the results of these two populations. The ELSA-Brasil MSK is an ancillary study of ELSA-Brasil and comprises 2,901 individuals with data on musculoskeletal health at baseline, including knees and hands radiographs. For the present analysis, we selected subjects ≥50 years older. In the ELSA-Brasil MSK, SU was assessed at visit 1 (2008-2010) and ROA at visit 2 (2012-2014); in the FHS, SU was assessed at exams 20 and 21 (1986-1992) and ROA at exam 22 (1990-1994) in original cohort. ROA of each tibiofemoral joint was defined as KL ≥2. SU was categorized as: < 5mg/dL, 5-< 6mg/dL, 6-< 7mg/dL, 7-< 9mg/dL, and ≥9mg/dL. The sex-specific relation of SU to the prevalence of knee ROA was evaluated using logistic regression, adjusted for age and BMI, with generalized estimating equations to account for the correlations of joints within individuals. The same analyses were performed with SU as a continuous variable.

Results: SU and radiographic data were available for 972 men and 1,124 women from the ELSA-Brasil MSK cohort and 329 men and 575 women from the FHS. Of those, 191, 229, 89, and 156 had knee OA, respectively. Age and BMI are shown in Table 1. In both cohorts after adjusting for age and BMI, men with SU ≥ 9 mg/dL had a significantly higher prevalence of knee ROA compared with those with SU < 5 mg/dL: OR 2.46 (CI 1.09-5.52, p=0.029) in the ELSA-Brasil MSK cohort and OR 3.31 (CI 1.28-8.55, p=0.013) in the FHS. In the analyses with SU as a continuous variable, the prevalence of knee ROA among men and women was 1.1 times higher for each mg/dL increment of SU in both cohorts, reaching statistical significance among men from the ELSA-Brasil MSK cohort (Table 2).

Conclusion: There seemed to be a threshold effect of SU to ROA at least among men, although this could not be properly evaluated among women due to the small number of subjects in the female highest stratum of SU.

Funding: ELSA-Brasil is supported by the Brazilian Ministry of Health and of Science and Technology (FINEP and CNPq-BR), (Grants 01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ). ELSA-Brasil MSK has been supported by CAPES-BR (054/2010), FAPEMIG-BR (APQ-00921-16), and CNPq-BR (42358520169).

SD: standard deviation.

*Adjusted for age and body mass index. OA: osteoarthritis; OR: odds ratio; CI: confidence interval.


Disclosures: A. Vargas-Santos, Abbvie, 6, 12, Financial support to participate in medical events, Janssen, 12, Financial support to participate in medical events, Novartis, 12, Financial support to participate in medical events, Boehringer Ingelheim, 12, Financial support to participate in medical events; T. Neogi, Pfizer/Lilly, 2, Regeneron, 2, Novartis, 2; L. Machado, None; I. Beseñor, None; L. Costa-Silva, None; D. Felson, None; S. Barreto, None; R. Telles, GSK Brasil, 12, Financial support to participate in medical event.

To cite this abstract in AMA style:

Vargas-Santos A, Neogi T, Machado L, Beseñor I, Costa-Silva L, Felson D, Barreto S, Telles R. The Relation of Serum Urate to Radiographic Knee Osteoarthritis in 2 Cohorts: The ELSA-Brasil MSK and the Original Cohort of the Framingham Heart Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-relation-of-serum-urate-to-radiographic-knee-osteoarthritis-in-2-cohorts-the-elsa-brasil-msk-and-the-original-cohort-of-the-framingham-heart-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-relation-of-serum-urate-to-radiographic-knee-osteoarthritis-in-2-cohorts-the-elsa-brasil-msk-and-the-original-cohort-of-the-framingham-heart-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology